The global 3D medical imaging devices market size was estimated at USD 10.8 billion in 2017. It is anticipated to expand at a CAGR of 5.9% during the forecast period. The rise in the global geriatric population coupled with the increase in cases of road traffic accidents is expected to drive the growth. Moreover, advancements in 3D imaging technology and investments by government and private organizations are other prime factors propelling the market.
According to a United Nations (UN) report published in 2017, people aged 65 and above accounted for approximately 13.0% of the total global population. This number is growing at the rate of 3.0% annually. The geriatric population is more prone to musculoskeletal diseases and joint problems. Osteoarthritis is the most common problem for old age people more than 65 years and is accompanied by increased mortality, and decreased quality of life. The global rise in the incidence of chronic and life-threatening diseases is the major driver for the market.
The emergence of automated 3D imaging scanners and ongoing R&D development in contrast agents used for 3D imaging is also expected to propel market growth. For instance, in July 2018, GE Healthcare introduced ready to drink an oral solution, Omnipaque (Iohexol) in the U.S. The solution acts as a contrast media and aids in visualization in the gastrointestinal tract.
Moreover, according to the U.S. Centers for Disease and Control (CDC), the participation in organized sports has witnessed a rise in the U.S. Approximately 2 million injuries, 0.5 million doctor visits, and 30,000 hospitalizations are recorded among the 30 million adults from the U.S. participating in sports each year. This has opened new opportunities for 3D medical imaging devices due to the increasing demand for point-of-care imaging coupled with a high addressable population.
On the basis of device type, the 3D medical imaging devices market is classified into X-ray, Computed Tomography (CT) devices, ultrasound systems, and Magnetic Resonance Imaging (MRI) equipment. In 2017, the CT segment accounted for the major market share. The nuclear imaging segment is anticipated to expand at the highest CAGR over the forecast period due to high demand for an increasing incidence of cancer cases, globally.
The ultrasound systems segment is expected to register a CAGR of approximately 7.0% over the forecast period. The high growth is attributed to the increase in ultrasound scans across the world and new product launches by the industry behemoths. For instance, in June 2018, Siemens Healthineers introduced a new ultrasound system Acuson Sequoia. The system features contrast-enhanced ultrasound imaging, and its BioAcoustic technology increases the bubble longevity and sensitivity and reduces the diagnosis time.
Based on application, the market is segmented into oncology, cardiology, and orthopedic. The orthopedic segment accounted for the largest market share in 2017, whereas, the cardiology segment is anticipated to register the highest CAGR in the market for 3D medical imaging devices over the forecast period.
The growth in the orthopedic segment is attributed to the rise in road traffic accidents and a high number of geriatric population with musculoskeletal disorders. As per the International Osteoporosis Foundation (IOF), an estimated 8.9 million fractures occur every year, which are attributable to osteoporosis and the disease affects more than 75 million people in Europe, U.S., and Japan.
Based on solutions, the market is segmented into 3D scanning, rendering, and modeling. In 2017, 3D rendering accounted for the largest market share. This growth can be attributed to the efficient ray-tracing algorithms of 3D rendering solutions for organ visualization.
The 3D modeling segment is expected to register the highest CAGR over the forecast period. The growth can be accredited to the increasing usage of 3D modeling anatomical models in surgical procedures. These solutions save time and enable surgeons to perform surgeries efficiently.
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA). North America, followed by Europe, collectively accounted for more than 60% market share in 2017. The growth of the North American region is attributed to the higher purchasing power of the healthcare settings, such as hospitals, long-term care centers, and advanced specialty centers. Moreover, well-established healthcare infrastructure compared to developing regions coupled with favorable reimbursement scenarios is anticipated to bode well for regional growth during the forecast period.
Asia Pacific is estimated to exhibit significant growth by 2026 driven by improving healthcare infrastructure and rising medical tourism. However, the high cost of 3D medical imaging devices and low adoption rate are some of the factors hindering the growth of the regional market.
The key market players include Siemens Healthineers; Esaote SpA; Koninklijke Philips N.V.; GE Healthcare Ltd.; Canon Medical Systems; Hitachi Medical Systems; Shimadzu Corporation; DigiRad Corporation; and Del Medical Systems Inc. These players focus on launching new products. For instance, in October 2018, Siemens unveiled its MAGNETOM RT Pro edition for MAGNETOM Sola, a new version of its 1.5 Tesla MRI scanner at its 60th annual meeting in the American Society for Radiation Oncology (ASTRO). The scanner includes in-built software and hardware and is designed to assist in radiation therapy treatments.
Report Attribute |
Details |
Market size value in 2020 |
USD 13.7 billion |
Revenue forecast in 2026 |
USD 20.8 billion |
Growth Rate |
CAGR of 5.9% from 2018 to 2026 |
Base year for estimation |
2017 |
Historical data |
2013 - 2016 |
Forecast period |
2018 - 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2018 to 2026 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Device type, application, solution, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; China; Japan; Mexico; Brazil; South Africa; Saudi Arabia |
Key companies profiled |
Siemens Healthineers; Esaote SpA; Koninklijke Philips N.V.; GE Healthcare Ltd.; Canon Medical Systems; Hitachi Medical Systems; Shimadzu Corporation; DigiRad Corporation; Del Medical Systems Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2013 to 2026. For the purpose of this study, Grand View Research has segmented the global 3D medical imaging devices market report on the basis of device type, application, solution, and region:
Device Type Outlook (Revenue, USD Million, 2013 - 2026)
X-ray Devices
CT
Ultrasound Systems
MRI
Application Outlook (Revenue, USD Million, 2013 - 2026)
Oncology
Cardiology
Orthopedic
Solution Outlook (Revenue, USD Million, 2013 - 2026)
3D Scanning
3D Rendering
3D Modeling
Regional Outlook (Revenue, USD Million, 2013 - 2026)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia Pacific
Japan
China
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
Saudi Arabia
b. The global 3D medical imaging devices market size was estimated at USD 12.6 billion in 2019 and is expected to reach USD 13.7 billion in 2020.
b. The global 3D medical imaging devices market is expected to grow at a compound annual growth rate of 5.9% from 2019 to 2026 to reach USD 20.8 billion by 2026.
b. CT segment dominated the 3D medical imaging devices market with a share of 25.7% in 2019. This is attributable to high demand for the increasing incidence of cancer cases, globally.
b. Some key players operating in the 3D medical imaging devices market include Siemens Healthineers; Esaote SpA; Koninklijke Philips N.V.; GE Healthcare Ltd.; Canon Medical Systems; Hitachi Medical Systems; Shimadzu Corporation; DigiRad Corporation; and Del Medical Systems Inc.
b. Key factors that are driving the market growth include a rise in the global geriatric population coupled with the increase in cases of road accidents.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.